Nasonex Indications Will Help Deflect Competition From Allermist, Schering-Plough Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Company believes mometasone’s broader label, which includes indications for allergy symptoms in children two years and older, will differentiate the product from GlaxoSmithKline’s Flonase follow-on.